Harm reduction Study Guide

📖 Core Concepts Harm Reduction – Public‑health strategies that lower the negative health and social impacts of risky behaviours (e.g., drug use, unsafe sex) without requiring abstinence. Target Populations – People experiencing homelessness, food insecurity, or engaging in risk‑prone activities such as illicit drug use or unprotected sex. Key Principle – “Positive change is possible even if the behaviour continues.” Opioid Agonist Therapy (OAT) – Use of a safer opioid (methadone) or partial agonist (buprenorphine/buprenorphine‑naloxone) to curb cravings and illegal opioid use. Naloxone – Opioid antagonist that displaces opioids from brain receptors, reversing respiratory depression in 2–8 min. Safer Supply – Prescribed regulated drugs (opioids, stimulants, benzos) that replace contaminated street drugs. Supervised Injection Site (SIS) – Legally sanctioned, medically staffed venues where people can inject safely and receive health services. --- 📌 Must Remember Needle‑exchange programs ↓ self‑reported injecting risk behaviour (2010 review). SIS → ↓ public injecting, ↓ syringe sharing, ↑ treatment uptake. OAT outcomes: 40‑65 % achieve abstinence; 70‑95 % reduce use & related harms. Naloxone is on WHO’s Essential Medicines list; availability at overdose time cuts deaths. Safer supply aims to replace fentanyl‑laced street drugs but may cause intoxication. Alcohol harm‑reduction – Designated‑driver & free‑taxi programs ↓ drunk‑driving crashes. Cannabis decriminalisation → little/no rise in use; reduces enforcement costs. Tobacco harm‑reduction – Snus, vaping, low‑tar cigarettes are offered as less‑harmful alternatives (long‑term safety still uncertain). Sex‑work harm‑reduction – Clean equipment, condoms, peer education ↓ HIV rates; decriminalisation expands access. --- 🔄 Key Processes Needle‑Exchange Workflow Distribute sterile syringes (free or trade‑in). Collect used needles → safe disposal. Provide HIV/HCV education & referrals. Naloxone Overdose Response Recognize overdose (respiratory depression, pinpoint pupils). Call emergency services. Administer naloxone intranasally or intramuscularly. Monitor breathing; repeat dose if no response after 2‑3 min. Opioid Agonist Therapy Initiation Assess opioid dependence → choose methadone (daily clinic) or buprenorphine (prescription). Start with low dose, titrate to suppress cravings. Provide counseling & regular urine screens. Supervised Injection Site Operation Client checks‑in → receives sterile equipment & info. Inject under staff observation → immediate medical assistance if needed. Offer referrals (detox, treatment, primary care). --- 🔍 Key Comparisons Methadone vs. Buprenorphine Methadone: Daily clinic dosing, full opioid agonist, higher risk of accumulation. Buprenorphine: Partial agonist, can be prescribed for take‑home use, lower overdose risk. Needle‑Exchange vs. Supervised Injection Site NEP: Supplies clean needles; no on‑site consumption. SIS: Provides clean needles plus a safe place to inject and immediate medical care. Safer Supply vs. Traditional OAT Safer Supply: Prescribes a broader range of regulated drugs (including stimulants/benzodiazepines); more flexible dosing. OAT: Focuses on opioid agonists only; stricter monitoring. Abstinence‑Only vs. Harm‑Reduction Sex Education Abstinence‑Only: Promotes no‑sex message; little impact on HIV or pregnancy. Harm‑Reduction: Accepts sexual activity, teaches condom use & negotiation; lowers unprotected intercourse and unintended pregnancies. --- ⚠️ Common Misunderstandings “Harm reduction encourages drug use.” – It does not promote use; it simply reduces harms while the behaviour continues. “Needle exchange eliminates HIV completely.” – It reduces incidence; other factors (e.g., condom use, treatment) are also needed. “Safer supply means people get high without risk.” – It replaces unpredictable illicit drugs with regulated ones, but intoxication can still occur. “Supervised injection sites cure addiction.” – They reduce acute harms and improve treatment uptake, but do not replace comprehensive addiction care. --- 🧠 Mental Models / Intuition “Safety Net” Model – View each program (NEP, SIS, naloxone) as a net catching people before they fall into severe health crises. “Continuum of Care” – Imagine a sliding scale: from no contact (abstinence‑only) → minimal contact (NEP) → high contact (SIS, OAT) → full treatment. The more contact, the greater the opportunity to intervene. “Risk Substitution” – Swapping a high‑risk method (sharing needles) for a low‑risk one (clean needle) dramatically cuts transmission, even if the underlying drug use persists. --- 🚩 Exceptions & Edge Cases Safer Supply Intoxication – Flexible dosing can lead to unintended intoxication, especially with stimulants/benzodiazepines. Limited Hepatitis C Evidence – Needle‑exchange shows tentative benefit for HCV reduction; strong data are lacking. Supervised Injection Site Evidence Gaps – Weak study designs limit definitive conclusions on HIV/HCV incidence reductions. 2025 BC Study – Safer‑supply and decriminalisation did not lower opioid‑overdose hospitalizations; both were linked to higher overdose rates. --- 📍 When to Use Which If the goal is immediate overdose reversal → Deploy naloxone (community distribution). When aiming to curb blood‑borne infections among PWID → Implement needle‑exchange (and consider adding SIS if resources allow). For long‑term opioid dependence management → Choose OAT (methadone for high‑dose users; buprenorphine for those needing take‑home flexibility). If the community faces widespread fentanyl contamination → Consider safer‑supply (with careful monitoring). For adolescent sexual health → Use harm‑reduction sex education (condom distribution, negotiation skills) rather than abstinence‑only curricula. --- 👀 Patterns to Recognize “Reduction + Referral” – Most programs pair a harm‑reduction service (e.g., clean needles) with a referral to treatment or health care. “Policy → Health Outcome” – Decriminalisation or legalisation often precedes lower enforcement costs and stable or reduced usage rates. “High‑Risk Population + Targeted Service = Measurable Drop in Acute Harm” – e.g., PWID + SIS → ↓ public injecting & overdose deaths. --- 🗂️ Exam Traps Distractor: “Needle‑exchange programs eliminate HIV.” – Wrong; they reduce but do not eradicate transmission. Distractor: “Safer supply programs guarantee no overdose.” – Wrong; they can still cause intoxication and overdose. Distractor: “Supervised injection sites are proven to lower HIV incidence.” – Wrong; methodological limits prevent definitive claims. Distractor: “Abstinence‑only sex education reduces HIV risk.” – Wrong; evidence shows no impact on HIV in developed countries. Distractor: “All critics of harm reduction oppose any drug policy reform.” – Wrong; some oppose specific aspects (e.g., perceived promotion of use) while supporting broader public‑health measures. ---